BRIAN BREDVIK
SPRINGFIELD, MA NPI 1689660284
Browse related groups: MA Tarsus Pharmaceuticals, Inc. All categories
General Payments — all program years on this page
$1,124.31
- Category: General Payments
- Program years: PY2018–2024
- Record count: 47
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $207.64 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $207.64 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Tarsus Pharmaceuticals, Inc. | $75.95 | 2 |
| Alcon Laboratories Inc | $46.06 | 2 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $27.50 | 1 |
| Dompe US, Inc. | $25.34 | 1 |
| Bausch & Lomb Americas Inc. | $16.57 | 1 |
| Oyster Point Pharma, Inc. | $16.22 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1110571491 | Alcon Vision LLC | $21.79 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1110571493 | Alcon Vision LLC | $24.27 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139084608 | Tarsus Pharmaceuticals, Inc. | $36.54 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139084610 | Tarsus Pharmaceuticals, Inc. | $39.41 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1140314386 | Bausch & Lomb Americas Inc. | $16.57 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1147415644 | Oyster Point Pharma, Inc. | $16.22 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1151398906 | Dompe US, Inc. | $25.34 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1152131218 | SUN PHARMACEUTICAL INDUSTRIES INC. | $27.50 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.